Louise R Rodino-Klapac

ORCID

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 5

Top Venues

Nature medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Jerry R Mendell, Eric R Pozsgai, Sarah Lewis, Danielle A Griffin, Linda P Lowes, Lindsay N Alfano, Kelly J Lehman, Kathleen Church, Natalie F Reash, Megan A Iammarino, Brenna Sabo, Rachael Potter, Sarah Neuhaus, Xiaoxi Li, Herb Stevenson, Louise R Rodino-Klapac
Gene therapy with bidridistrogene xeboparvovec for limb-girdle muscular dystrophy type 2E/R4: phase 1/2 trial results. Nature medicine 30 (1) (2024)
Jerry R Mendell, Eric R Pozsgai, Sarah Lewis, Danielle A Griffin, Linda P Lowes, Lindsay N Alfano, Kelly J Lehman, Kathleen Church, Natalie F Reash, Megan A Iammarino, Brenna Sabo, Rachael Potter, Sarah Neuhaus, Xiaoxi Li, Herb Stevenson, Louise R Rodino-Klapac
Gene therapy with bidridistrogene xeboparvovec for limb-girdle muscular dystrophy type 2E/R4: phase 1/2 trial results. Nature medicine (2024)
Jerry R Mendell, Eric R Pozsgai, Sarah Lewis, Danielle A Griffin, Linda P Lowes, Lindsay N Alfano, Kelly J Lehman, Kathleen Church, Natalie F Reash, Megan A Iammarino, Brenna Sabo, Rachael Potter, Sarah Neuhaus, Xiaoxi Li, Herb Stevenson, Louise R Rodino-Klapac
Gene therapy with bidridistrogene xeboparvovec for limb-girdle muscular dystrophy type 2E/R4: phase 1/2 trial results. Nature medicine 30 (1) (2024)
Jerry R Mendell, Eric R Pozsgai, Sarah Lewis, Danielle A Griffin, Linda P Lowes, Lindsay N Alfano, Kelly J Lehman, Kathleen Church, Natalie F Reash, Megan A Iammarino, Brenna Sabo, Rachael Potter, Sarah Neuhaus, Xiaoxi Li, Herb Stevenson, Louise R Rodino-Klapac
Gene therapy with bidridistrogene xeboparvovec for limb-girdle muscular dystrophy type 2E/R4: phase 1/2 trial results. Nature medicine 30 (1) (2024)
Jerry R Mendell, Eric R Pozsgai, Sarah Lewis, Danielle A Griffin, Linda P Lowes, Lindsay N Alfano, Kelly J Lehman, Kathleen Church, Natalie F Reash, Megan A Iammarino, Brenna Sabo, Rachael Potter, Sarah Neuhaus, Xiaoxi Li, Herb Stevenson, Louise R Rodino-Klapac
Gene therapy with bidridistrogene xeboparvovec for limb-girdle muscular dystrophy type 2E/R4: phase 1/2 trial results. Nature medicine 30 (1) (2024)

Louise R Rodino-Klapac.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Louise R Rodino-Klapac